In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Co-planar stereotaxic atlas of the human brain : 3-dimensional proportional system : an approach to cerebral imaging

Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Simplified Reference Tissue Model for PET Receptor Studies

Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,025

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802

Untitled work

Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284

Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099

PET Neuroimaging in Dementia Conditions

Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20

Reprint of: Microglial toll-like receptors and Alzheimer’s disease

Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 19

Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation

Castelnovo, V., Caminiti, S. P., Riva, N., Magnani, G., Silani, V., & Perani, D. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3685-7 · Cited by 20

Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer

Makrakis, D., Holt, S. K., Bernick, C. B., Grivas, P. D., Gore, J. L., & Wright, J. L. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000530 · Cited by 19

New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives

Marchi, F. D., Vignaroli, F., Mazzini, L., Comi, C., & Tondo, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230608110201 · Cited by 19

Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer’s Disease

Jorge, L., Martins, R., Canário, N., Xavier, A. C., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200840 · Cited by 19

Combined royal jelly 10-hydroxydecanoic acid and aspirin has a synergistic effect against memory deficit and neuroinflammation

You, M., Wang, K., Pan, Y., Tao, L., Ma, Q., Zhang, G., & Hu, F. (2022) · Food & Function · doi:10.1039/d1fo02397g · Cited by 17

Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer’s disease

Canário, N., Jorge, L., Martins, R., Santana, I. J., & Castelo-Branco, M. S. (2022) · Communications Biology · doi:10.1038/s42003-022-03761-7 · Cited by 21

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia

Ying, C., Kang, P. M., Binkley, M. M., Ford, A. L., Chen, Y., Hassenstab, J. J., Wáng, Q., Strain, J. F., Morris, J. C., Lee, J., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103373 · Cited by 18

Distinct binding of amyloid imaging ligands to unique amyloid‐β deposited in the presubiculum of Alzheimer's disease

Ji, B., Chen, C.-J., Bando, K., Ashino, H., Shiraishi, H., Sano, H., Kasahara, H., Minamizawa, T., YAMADA, K., Ono, M., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13293 · Cited by 17

Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging

Komori, S., Cross, D. J., Mills, M. K., Ouchi, Y., Nishizawa, S., Okada, H., Norikane, T., Thientunyakit, T., Anzai, Y., & Minoshima, S. (2022) · Annals of Nuclear Medicine · doi:10.1007/s12149-022-01775-z · Cited by 15

Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4/NF-кB signaling in aged mice

Chen, F., Wu, X., Yang, J., Yu, X., Liu, B., & Yan, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175360 · Cited by 14

PET Imaging to Measure Neuroinflammation In Vivo

Malpetti, M., Franzmeier, N., & Brendel, M. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_12 · Cited by 14

New PET markers for the diagnosis of dementia

Payoux, P., & Salabert, A. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000489 · Cited by 14

Advance and Prospect of Positron Emission Tomography in Alzheimer’s disease research

Wang, Y., Liao, W., Wang, L., Li, J., Huang, D., Cheng, W., Tian, J., & Luan, P. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03081-2 · Cited by 13

The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions

Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 14

Molecular imaging of neuroinflammation in Alzheimer’s disease

Varrone, A., & Nordberg, A. K. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0137-8 · Cited by 13

Different Patterns of Glucose Hypometabolism Underlie Functional Decline in Frontotemporal Dementia and Alzheimer’s Disease: FDG-PET Study

Fukai, M., Hirosawa, T., Kikuchi, M., Hino, S., Kitamura, T., Ouchi, Y., Yokokura, M., Yoshikawa, E., Bunai, T., & Minabe, Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000365 · Cited by 13

Neuroinflammation in dementia: A meta-analysis of PET imaging studies

Pan, J., Hu, J., Meng, D., Chen, L., & Wei, X. (2024) · Medicine · doi:10.1097/md.0000000000038086 · Cited by 11

Molecular PET Imaging in Alzheimer’s Disease

Thientunyakit, T., Shiratori, S., Ishii, K., & Gelovani, J. G. (2022) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-022-00717-4 · Cited by 12

Neuroinflammation to neurodegeneration: Boulevard of broken nerves

Attiq, A., Afzal, S., Raman, H., & Ahmad, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115015 · Cited by 12

Molecular neuroimaging in degenerative dementias

Jiménez-Bonilla, J. F., & CARRIL, J. M. (2013) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2013.07.027 · Cited by 10

Review Article Neuroinflammation in Alzheimer's disease: Current evidence and future directions

Calsolaro, V., & Edison, P. (2016) · Cited by 10

La neuroimagen molecular en las demencias degenerativas

Jiménez-Bonilla, J. F., & CARRIL, J. M. (2013) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2013.06.012 · Cited by 9

Biomarkers for Alzheimer’s Disease

Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00007-0 · Cited by 9

Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer’s Disease

Bunai, T., Kakimoto, A., Yoshikawa, E., Terada, T., & Ouchi, Y. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181188 · Cited by 6

Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

Sil, M., Mukherjee, N., Chatterjee, I., Ghosh, A., & Goswami, A. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02379-8 · Cited by 9

Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment

Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010946 · Cited by 7

Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study

Kemna, R. E., Kueck, P. J., Blankenship, A. E., John, C. S., Johnson, C. N., Green, Z. D., Mayfield, H. D., Yoksh, L., Johnson, L. A., Thyfault, J. P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70984 · Cited by 6

The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease

Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6

Perspectives in TSPO PET Imaging for Neurologic Diseases

Song, Y. S. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00620-y · Cited by 6

Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review

Machado, L. S., Vidor, P. R., Perquim, L., Limberger, C., Machado, L., da Rocha, A. S., Soares, C., Rahmouni, N., Brum, W. S., Bellaver, B., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03160-4 · Cited by 5

Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects

Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230442 · Cited by 5

Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment

Kim, J., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_14 · Cited by 3

Diet‐induced diabetes is associated with lower hippocampal glycogen and reduced glycogenolysis following local exogenous insulin

McNay, E. C. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16001 · Cited by 4

Frontal neurodegeneration associated with Frontal Assessment Battery in early Alzheimer's disease

Terada, T., Kubota, M., Miyata, J., Obi, T., Takashima, H., Matsudaira, T., Bunai, T., Ouchi, Y., & Murai, T. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123327 · Cited by 4

Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions

Villemagne, V. L., Fodero‐Tavoletti, M. T., Yates, P. A., Masters, C. L., & Rowe, C. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_10 · Cited by 4

PET Imaging of Translocator Protein Expression in Neurological Disorders

Brooks, D. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_30 · Cited by 4

Neurochemical Aspects of Alzheimer’s Type of Dementia

Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00003-9 · Cited by 4

SPECT/PET Findings in Lewy Body Dementia

Ducksbury, R., Whitfield, T. J., & Walker, Z. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_17 · Cited by 3

Good manufacturing practice production of the system A amino acid transport tracer [11C]MeAIB on a commercial synthesis module

Dam, J. H., & Någren, K. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3139 · Cited by 3

Microglial activation is raised in preclinical Alzheimer’s disease and associated with covert memory impairment

Kjeldsen, P. L., Madsen, L. S., Parbo, P., Ismail, R., Aanerud, J., Kaasing, M., Damholdt, M. F., Eskildsen, S. F., Østergaard, L., & Brooks, D. J. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2025.1745571 · Cited by 2

Research progress in neuroimaging of sporadic early-onset Alzheimer’s disease

Zhang, X., & Yang, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788814 · Cited by 2

PET Imaging of Translocator Protein Expression in Neurological Disorders

Brooks, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_22 · Cited by 2

A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-β Oligomers in Mice

Siqueira, L. D., Celes, A. P. M., dos Santos, H., & Ferreira, S. T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210139 · Cited by 2

Neuroinflammation in Alzheimer's Disease

(2020) · Case Medical Research · doi:10.31525/ct1-nct04274998 · Cited by 2

Parietal matters in early Alzheimer's disease : evidence from structural and functional MRI

Jacobs, H. I. L. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110706hj · Cited by 1

Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions

Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2

The relation between neuroinflammation, amyloid-β load, grey matter loss and brain activity in visual object recognition regions in Alzheimer's Disease

Jorge, L., Canário, N., Martins, R., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100305 · Cited by 1

Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice

Tian, M., Feng, R., Gong, C., Ben, X., Ma, Z., Yi, X., & Guo, Q. (2026) · Biomolecules · doi:10.3390/biom16060798 · Cited by 1

The Role of Adaptive and Innate Immunity in Alzheimer’s Disease

Holmes, C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.012 · Cited by 1

Textural properties of microglial activation in Alzheimer’s disease as measured by (R)-[11C]PK11195 PET

Pais, M. L., Jorge, L., Martins, R., Canário, N., Xavier, A. C., Bernardes, R., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2023) · Brain Communications · doi:10.1093/braincomms/fcad148 · Cited by 1

Brain PET Poster Sessions PP01-M01 to PP02-N07

Lange, D., Tejada, I. M., xiong, M., Hillebrand, B., Noergaard, M., Baerentzen, S., Shalgunov, V., Herth, M. M., Svarer, C., & Palner, M. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19851018 · Cited by 1

How molecular imaging studies can disentangle disease mechanisms in age-related neurodegenerative disorders

de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1

Blood-Brain Barrier Permeability and Inflammation in Cerebral Small Vessel Disease

Walsh, J. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.50869 · Cited by 2

Meta analysis of glucose metabolism across Alzheimer’s, Parkinson’s and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profilesPreprint

Raikes, A., Garza, M., Murrell, A. N., & Brinton, R. D. (2026) · medRxiv · doi:10.64898/2026.04.07.26350339 · Cited by 1

In VivoImaging of Glial and Immune Cell Responses in Central Nervous System Injury and Disease

Paré, A., & Lacroix, S. (2015) · Wiley eBooks · doi:10.1002/9781118732748.ch2

Investigation of the Effects of Image Signal-to-Noise Ratio on TSPO PET Quantification of Neuroinflammation

Constable, C. (2013) · The Sydney eScholarship Repository (The University of Sydney)

Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease

Malmsten, L. (2014) · Figshare

PET Imaging in Neuroinflammation

Brooks, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_9

Linking Molecular Neurobiology to Therapeutic Approaches for Alzheimer’s Disease with PET

Luiten, P. G. M., Masman, M. F., Dobos, N., Nyakas, C. J., de Vries, E. F. J., Dierckx, R., & Eisel, U. L. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_20

in vivo 分子画像法を用いた脳内活性ミクログリアの描出

尾内康臣 (2015) · doi:10.11249/jsbpjjpp.26.3_134

Microglial activation in healthy adult Japanese subjects: apositron emission tomography study

Ikuma, M., Ouchi, Y., Nakaizumi, K., Yokokura, M., Takebayashi, K., Suzuki, K., & Mori, N. (2016) · Journal of brain science · doi:10.20821/jbs.46.0_55

Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development

Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6

Revista Brasileira de Psiquiatria

Benadiba, M., Luurtsema, G., Wichert‐Ana, L., Buchpiguel, C. A., & Busatto, G. F. (2012)

Central Nervous System Molecular Imaging

Sólnes, L. B., Jacobs, A. H., Coughlin, J. M., Du, Y., Goel, R., Hammoud, D. A., & Pomper, M. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00088-0

Alzheimer’s Disease

Roytman, M., Gordon, M. L., & Franceschi, A. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_22

DHA for Optimal Health

Meyer, B. J. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-972-2

Faculty Opinions recommendation of Neuroinflammation in Alzheimer's disease.

Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725413893.793537457

Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease

Fairley, L. H. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/160865

Dementia

(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00026-5

Fibrotic Disease: from Signaling Pathways and Biomarkers to Molecular Imaging

Ghazaiean, M., Riss, P. J., Mardanshahi, A., & Molavipordanjani, S. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-02038-9

Etudes de trois métalloprotéases matricielles, MT1-MMP, MT5-MMP et MMP-12 dans l'amyloïdogenèse et les atteintes inflammatoires et vasculaires associées à la maladie d'Alzheimer

Bonnet, A. (2017) · theses.fr (ABES) · doi:10.70675/7fa1337ez8c86z4faezb643z1ee618bb3cfa

Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie

Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513

Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study

Schuitemaker, A., Kropholler, M. A., Boellaard, R., van der Flier, W. M., Kloet, R. W., van der Doef, T. F., Knol, D. L., Windhorst, A. D., Luurtsema, G., Barkhof, F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.021 · Cited by 175

Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease

Wiley, C. A., Lopresti, B. J., Venneti, S., Price, J. C., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 160

[PL1‐01]: The relationship between amyloid load, microglial activation, and cognition in Alzheimer's disease: PET findings

Brooks, D. J., Edison, P., Archer, H. A., Hinz, R., Gerhard, A., Hammers, A., Pavese, N., Tai, Y., Cuttler, D., Fox, N. C., et al. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.053

P.4.a.001 Clinical and sociodemographic features of patients with obsessive-compulsive disorder

Yildirim, E. A., Kaşar, M., Ozcan, E., Albayrak, E., Gökalp, R. P., & Ozer, S. (2009) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(09)70937-x